"Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale," by Rupesh Kotecha and Minesh Mehta

Menu

Skip to main content

All Publications

Rupesh Kotecha, Miami Cancer InstituteFollow
Minesh Mehta, Miami Cancer InstituteFollow

Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale, Dose, Techniques, and Outcomes

Publication Date

8-17-2020

Content Type

Article

PubMed ID:

Citation

Neuro-Oncology (2020) 22(8):1062-1064

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS